{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Latest Videos

{{ currentStream.Name }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

More Video

Feb 23, 2022

Bausch Health reports US$69M Q4 profit compared with loss a year ago

The headquarters of Bausch Health Solutions, formerly known as Valeant Inc.

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

LAVAL, Que. -- Bausch Health Companies Inc. reported a profit in its latest quarter compared with a loss a year earlier.

The company, which keeps is books in U.S. dollars, says it its profit attributable to Bausch Health totalled US$69 million or 19 cents per share for the quarter ended Dec. 31, compared with a loss of US$153 million or 43 cents per diluted share in the same quarter a year earlier.

Revenue totalled nearly US$2.2 billion compared with $2.21 billion in the fourth quarter of 2020.

On an adjusted basis, the company says it earned US$463 million in the fourth quarter compared with an adjusted profit of US$478 million in the last three months of 2020.

In its outlook for 2022, Bausch Health says it expects revenue between US$8.4 billion and US$8.6 billion this year.

Full-year adjusted earnings before interest, taxes, depreciation and amortization are expected to be in a range from US$3.45 billion to US$3.6 billion.